scholarly journals P394 Are we consistent? A service evaluation of Infection Prevention and Control Practices (IP & CP) for cystic fibrosis physiotherapy in the UK

2019 ◽  
Vol 18 ◽  
pp. S169
Author(s):  
N. Leach ◽  
B. Millman
2020 ◽  
Vol 19 (3) ◽  
pp. 384-387 ◽  
Author(s):  
Sonja Meyer ◽  
Thomas Nüßlein ◽  
Lutz Nährlich ◽  
Jutta Bend ◽  
Barbara Gärtner ◽  
...  

2018 ◽  
Vol 19 (6) ◽  
pp. 302-309
Author(s):  
Sue Millward

Background: The Director of Infection Prevention and Control (DIPC) role was introduced into the UK in 2003 to address the need for effective leadership within Infection Prevention (IP). The role was embedded in English legislation in 2008. In one Independent healthcare organisation (with 31 acute hospitals spread geographically across the UK), the DIPC role is held by the hospital matron (known as Director of Nursing in the NHS), who influence resource allocation and ensure infection prevention is prioritised. A knowledge gap in microbiology, standard precautions and infection prevention regulatory requirements was identified and as there was no educational provision for this role, an accredited programme was developed. Twenty-five matrons completed the DIPC programme. Aims: Evaluate the impact of a DIPC educational programme on the delivery of IP services. Methodology: A post-course qualitative retrospective survey using open-ended questions was used to collect data from DIPCs who had completed the programme. Inductive thematic and content analysis methods were used to identify key themes from survey responses. Results: Out of 20 DIPCs, 16 completed the survey. Key findings included improvements in knowledge related to microbiology, IP and regulatory requirements of the DIPC role. DIPCs reported changes to service delivery including appointment of six IP nurses, improved surveillance processes, reduced infections and improved cleanliness standards. This small study demonstrates the impact of an educational programme for DIPCs who felt more empowered to manage the IP services effectively, resulting in improved patient safety through reduced infections.


2014 ◽  
Vol 35 (S1) ◽  
pp. s1-s67 ◽  
Author(s):  
Lisa Saiman ◽  
Jane D. Siegel ◽  
John J. LiPuma ◽  
Rebekah F. Brown ◽  
Elizabeth A. Bryson ◽  
...  

The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline for CF. During the past decade, new knowledge and new challenges provided the following rationale to develop updated IP&C strategies for this unique population:1.The need to integrate relevant recommendations from evidence-based guidelines published since 2003 into IP&C practices for CF. These included guidelines from the Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC), the World Health Organization (WHO), and key professional societies, including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). During the past decade, new evidence has led to a renewed emphasis on source containment of potential pathogens and the role played by the contaminated healthcare environment in the transmission of infectious agents. Furthermore, an increased understanding of the importance of the application of implementation science, monitoring adherence, and feedback principles has been shown to increase the effectiveness of IP&C guideline recommendations.2.Experience with emerging pathogens in the non-CF population has expanded our understanding of droplet transmission of respiratory pathogens and can inform IP&C strategies for CF. These pathogens include severe acute respiratory syndrome coronavirus and the 2009 influenza A H1N1. Lessons learned about preventing transmission of methicillin-resistantStaphylococcus aureus(MRSA) and multidrug-resistant gram-negative pathogens in non-CF patient populations also can inform IP&C strategies for CF.


Sign in / Sign up

Export Citation Format

Share Document